Further to our letter dated 20th February, 2025, wherein the Board recommend a final dividend of Rs. 55 per equity share, subject to the approval by the Members at the ensuing AGM, in this regard we ...

Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...

Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...

Among racial and ethnic groups, non-Hispanic white adults reported the highest rate of seasonal allergies (28.4%), followed ...

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other ...

Following the Food and Drug Administration’s approval of Lutathera and Pluvicto in 2018 and 2022, respectively, we predicted ...

The automaker wants to add Alice Schroeder and Daniel Ramot to its 11-seat board of directors, a shift toward North America.

The Critical Medicines Alliance Strategic Report has been published in a bid to develop a coordinated, European industrial ...

American Express Company (NYSE: AXP) today announced that Michael J. Angelakis has been elected to its Board of Directors, ...

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant ...

CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the fourth quarter and year ...